MedPath

Study comparing the performance status assessments reported by clinician versus patients themselves.

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2024/03/064160
Lead Sponsor
Dr Nandini Devi R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients who are planned for first cycle of cytotoxic chemotherapy

Exclusion Criteria

Those who cannot read,comprehend and answer the study questionnaire

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
level of agreement between patient-assessed and clinician-assessed performance status and compare the odds of these assessments in predicting 30-day morbidityTimepoint: Day 1 and Day-30
Secondary Outcome Measures
NameTimeMethod
Correlation of Performance status assessments with 30-day morbidityTimepoint: 30-day morbidity
© Copyright 2025. All Rights Reserved by MedPath